Acoustic Resonance Therapy for Treating Empty Nose Syndrome

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorStanford University

About this trial

This study is to determine whether Acoustic Resonance Therapy (ART), an FDA-approved treatment for standard nasal obstruction, may be helpful in mitigating the debilitating symptoms of Empty Nose Syndrome (ENS), which includes an alternative form of nasal obstruction. ART is a non-invasive treatment that uses sound vibrations to improve nasal congestion and other sinus symptoms. ART works by delivering specific frequencies of sound to the sinonasal cavities (nose and sinuses). These vibrations cause the tissues in the sinuses to resonate, which can help break up mucus and clear blockages, reduce inflammation, and improve airflow.

Eligibility criteria

Qualifiers

Documented case of Empty Nose Syndrome

Documented past turbinate reduction surgery

Disqualifiers

Neurocognitive diagnosis/decline

Trial design

Treatments tested in this trial

  • Personalized ART
  • Non-personalized ART

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Stanford University

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator